Toward Resilience: A Guide to Disaster Risk Reduction and Climate Change Adaptation

Submitted by Angela Kohama | published 1st Mar 2013 | last updated 13th Jan 2020
Toward Resilience: A Guide to Disaster Risk Reduction and Climate Change Adaptation

Toward Resilience is a small, user- friendly guide aimed at helping field practitioners implement effective, sustainable, and integrated Disaster Risk Reduction (DRR) and Climate Change adaptation (CCA) programming. The guide is organized around 10 guiding principles and features an extensive, well-organized tools and resources annex.  It provides guidance and case studies of incorporating DRR and CCA into new and existing programming and specifically addresses the needs of key vulnerable groups such as women, children, and high-risk communities. It explains how DRR and CCA can be integrated into program cycle management as well as issues around addressing advocacy and governance. It also focuses on how DRR and CCA can be applied in key sectors, such as food security, natural resource management, and education, as well as key contexts, such as conflict, early recovery, and urban areas.

Where to find it:

Toward Resilience is available for free in below languages:




This resource was produced by The Emergency Capacity Building (ECB) Project, working across multiple countries and using a field-focused, participatory process. The ECB Project aims to improve the speed, quality and effectiveness of the humanitarian community to save lives, improve welfare and protect the rights of people in emergency situations.  The ECB Project agencies include CARE International, Catholic Relief Services, Mercy Corps, Oxfam, Save the Children and World Vision International. ECB focuses on three themes for improving aid: 1) Staff Capacity; 2) Accountability and Impact Measurement; and 3) Disaster Risk Reduction; these themes are incorporated into context specific programming in the 5 ECB consortia countries: Bangladesh, Indonesia, Horn of Africa, Niger, and Bolivia.  Toward Resilience was generously supported by The Bill & Melinda Gates Foundation, ECHO, USAID/OFDA, and the Fidelity Charitable Trustees’ Philanthropy Fund.